Canada readies efforts to curtail drug traffic

Canadian officials say they're preparing to unveil new proposals that would put the brakes on the sale of drugs south of the border. One possible change would be to prevent Canadian doctors from signing a prescription for a patient they hadn't seen. That would be a big win for US drug companies, which have been lobbying hard to kill off the flow of less expensive Canadian meds to US customers.

- read this story from the Chicago Tribune

Suggested Articles

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.

The top-line readout appears to justify the risk the partners took when they advanced the drug despite missing the primary endpoint in phase 2.